Peijia Medical pockets HK$2.34bn from hot IPO

By Jonathan Breen
11 May 2020

Peijia Medical bagged HK$2.34bn ($302m) from its IPO after winning huge support from institutional and retail investors, according to a source close to the deal.

The Chinese medical device manufacturer launched a virtual roadshow for its IPO on May 5. The issuer opted to market its float of 152.5m shares at a fixed price of HK$15.36 per share.

Huatai and Morgan Stanley were the sponsors, as well as the global co-ordinators, bookrunners and ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial